Yanqun Sun

Dr. Yanqun Sun


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2025 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
FSFeifei Shen
Feifei Shen
YXYing Xu
Ying Xu
XJXusheng Jiang
Xusheng Jiang
LYLinjie Yu
Linjie Yu
HGHong-Han Ge
Hong-Han Ge
YSYanqun Sun
Yanqun Sun
To develop and evaluate machine learning models combined with survival analysis for predicting 7-, 14-, and 28-day mortality in critically ill children with acute kidney injury (AKI), identifying key predictors to guide risk stratification and early intervention. Using the Pediatric Intensive Care (PIC) database, we analyzed data from 3,624 children with AKI admitted between 2010 and 2018. Nine machine learning algorithms, including CatBoost, were trained to predict mortality, with feature importance assessed via SHapley Additive exPlanations (SHAP). Time-to-event analyses, including Kaplan-Meier and restricted cubic spline methods, examined the temporal impact of predictors on 28-day mortality, stratified by age and AKI stage. CatBoost achieved the highest area under the curve (AUC) values: 0.871 (95% CI: 0.824–0.918) for 7-day, 0.871 (95% CI: 0.829–0.913) for 14-day, and 0.867 (95% CI: 0.829–0.905) for 28-day mortality. Lactate was the top predictor across all models. Time-to-event analyses revealed a linear association between elevated lactate (cut-off: 1.5 mmol/L) and 28-day mortality (p-overall < 0.001), with stronger effects in infants (0–3 years) and AKI stage 1 patients (HR > 1). Machine learning, particularly CatBoost, combined with survival analysis, accurately predicts AKI-related mortality in critically ill children, with lactate as a pivotal marker. These findings support precision risk stratification and early lactate-targeted interventions, though multicenter validation is needed for clinical adoption.

13 June 2025 in One Health
Verified
Journal Article
Open access
YSYanqun Sun
Yanqun Sun
XZXiao-Yan Zhu
Xiao-Yan Zhu
TFTian-Ci Fan
Tian-Ci Fan
TMTian Ma
Tian Ma
HGHong-Han Ge
Hong-Han Ge
YTYe Tian
Ye Tian
Lyme disease, caused by Borrelia burgdorferi and transmitted by blacklegged ticks (Ixodes species), is the most common vector-borne disease in the United States. Its spatiotemporal dynamics are influenced by environmental and socioeconomic factors, yet the impacts of the COVID-19 pandemic on Lyme disease remain unclear. We analyzed county-level Lyme disease surveillance data (2001−2022) alongside environmental, socioeconomic, and tick vector data. Using machine learning models (Random Forest, Boosted Regression Trees, and XGBoost) and Shapley Additive Explanations (SHAP), we evaluated the influence of key predictors on Lyme disease risk. Predicted cases for 2020–2022 were compared with actual reports to assess the pandemic's effects. Lyme disease cases rose from 16,862 in 2001 to 61,802 in 2022, with geographic expansion into southeastern regions. Population density, ecological niche of I. scapularis, and maximum temperature were presented as the key predictors of disease risk. The COVID-19 pandemic severely disrupted reporting dynamics, with 2020 and 2021 cases falling 43.9 % (95 % CI: 41.2–46.7 %) and 22.0 % (95 % CI: 19.5–24.5 %) below predictions, respectively—a decline most pronounced in the Northeast and linked to reduced healthcare access and outdoor activity during lockdowns. Our findings highlight the complex interactions of environmental, socioeconomic, and behavioral factors in Lyme disease dynamics, including the significant impact of the COVID-19 pandemic on disease reporting. These insights underscore the need for integrated, data-driven public health strategies to mitigate Lyme disease risk in the United States.

24 April 2026 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
YHYingying Hu
Yingying Hu
JLJun Li
Jun Li
YZYixiang Zheng
Yixiang Zheng
YCYoude Cheng
Youde Cheng
WLWei Li
Wei Li
YSYanqun Sun
Yanqun Sun
The coronavirus disease 2019 (COVID-19) pandemic profoundly disrupted the global epidemiology of respiratory syncytial virus (RSV), leading to atypical off-season surges and altering infection dynamics across different climatic zones. This review synthesizes evidence on the landscape of pediatric RSV co-infections in this transformed post-pandemic context. RSV co-infection is frequent, with human rhinovirus (HRV) being the most common viral co-pathogen and Streptococcus pneumoniae (Spn) and Haemophilus influenzae (Hi) predominating as bacterial co-infections. Critically, these co-infections are significantly associated with heightened disease severity, including more intense clinical presentations, prolonged hospitalizations, increased intensive care unit (ICU) admission rates, and greater therapeutic complexity. The relaxation of non-pharmaceutical interventions has been linked to a rebound in co-infection rates. While advances in molecular diagnostics have improved detection, and new prophylactics like nirsevimab offer promise, significant challenges remain. These include gaps in understanding pathogenic synergies, inequities in access to novel interventions, and the need for strategies to manage the ongoing evolution of RSV epidemiology. This underscores the necessity for enhanced surveillance, equitable prevention, and targeted research to mitigate the substantial burden of pediatric RSV co-infections.

1 December 2025 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
YHYa-Qian Hu
Ya-Qian Hu
SXSheng-Fan Xue
Sheng-Fan Xue
RYRui-Zhe Yang
Rui-Zhe Yang
YBYu-Wen Bao
Yu-Wen Bao
HZHeng Zhang
Heng Zhang
YSYanqun Sun
Yanqun Sun
Serratia marcescens (S. marcescens) is a gram-negative opportunistic pathogen causing healthcare-associated infections in neonatal intensive care

20 January 2025 in Annals of Global Health
Verified
Journal Article
Open access
DBDandan Bai
Dandan Bai
WYWu Yan
Wu Yan
JCJinlong Chen
Jinlong Chen
SMSabitina Mrisho Mzava
Sabitina Mrisho Mzava
FBFrancis Manyori Bigambo
Francis Manyori Bigambo
YSYanqun Sun
Yanqun Sun
Background: Non-communicable diseases (NCDs) have surpassed infectious diseases as the leading cause of disability and mortality globally. However, the burden of NCDs among children and adolescents in the Asia-Pacific region remains underexplored. This study evaluates changes in NCD burden among individuals aged 0–19 years in the Asia-Pacific region from 1990 to 2021. Methods: Using data from the Global Burden of Diseases, Injuries, and Risk Factors (GBD) 2021 study, we estimated deaths, disability-adjusted life years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) with 95% uncertainty intervals (UIs). We analyzed changes in disease burden by age, sex, location, and socio-demographic index (SDI) between 1990 and 2021. Results: In 2021, NCDs accounted for a YLD rate of 56488.99 (95% UI: 40849.26–75780.79) and a death rate of 356.45 (95% UI: 280.27–433.27) per 100,000 population among children and adolescents aged 0–19 years. Other NCDs were the leading cause of death (167.08 [95% UI: 116.63–216.90]), YLLs (14584.60 [95% UI: 10126.88–18,962.14]), and DALYs (20327.20 [95% UI: 14815.25–26238.15]) per 100,000, while mental disorders led in YLDs. Death rates were higher in males, but DALYs were higher in females. From 1990 to 2021, NCD death rates decreased by 44.63% (from 643.71 [95% UI: 508.48–758.86] to 356.45 [95% UI: 280.27–433.27]) and YLLs by 45.49%. However, mental disorder-related deaths, YLLs, and DALYs increased by 29.26%, 29.16%, and 10.07%, respectively. Lower SDI countries reported higher NCD burdens, particularly for other NCDs. Conclusions: While the NCD burden among children and adolescents in the Asia-Pacific region decreased significantly from 1990 to 2021, the rising burden of mental disorders is a critical public health concern.

13 April 2026 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
YSYanqun Sun
Yanqun Sun
WSWenshen Shao
Wenshen Shao
XWXu Wang
Xu Wang
RYRuizhe Yang
Ruizhe Yang
WLWei Li
Wei Li
MTMan Tian
Man Tian
Objectives: To characterize the epidemiology, seasonal fluctuations, and co-infection networks of pediatric respiratory pathogens in eastern China following the relaxation of COVID-19 non-pharmaceutical interventions (NPIs). Methods: We conducted a retrospective analysis of 7,473 throat swab samples collected from children (≤18 years) presenting with acute respiratory tract infections (ARTIs) at a tertiary hospital in Nanjing between January 2024 and May 2025. Samples were tested for 13 common pathogens using a multiplex RT-PCR assay. Pathogen detection rates, temporal trends, and co-infection dynamics were analyzed using Kruskal-Wallis tests, time-series smoothing, and network analysis. Results: The overall pathogen detection rate was 61.8% (4,618/7,473), with no significant sex disparity (p = 0.267). Preschoolers (4–6 years) experienced the highest burden (68.3%), significantly exceeding other age groups (p < 0.008). Rhinovirus (RV, 16.9%), Mycoplasma pneumoniae (12.4%), and Respiratory Syncytial Virus (RSV, 9.0%) were the most prevalent pathogens. Distinct seasonal signatures were observed: RSV peaked in winter (25.3% in March 2025), M. pneumoniae dominated in mid-summer (22.8% in August 2024), and RV maintained high year-round activity. Co-infections occurred in 17.5% of positive samples, with M. pneumoniae-RV and Adenovirus-RV being the most frequent combinations. Network analysis identified RV and M. pneumoniae as central connectors within the intricate co-infection landscape. Conclusions: Pediatric respiratory pathogens have returned with strong, age-specific patterns in post-NPI eastern China. The pronounced “immunity debt” among preschoolers and the high rate of co-infections underscore the urgent need for enhanced multiplex surveillance and the expansion of vaccination programs for RSV and influenza.